- #Diseases of the nervous system
- #Mental and behavioural disorders
- #Musculoskeletal system and connective tissue
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 9000 people in approximately 40 countries, the company generated revenue of EUR 3.4 billion in 2012. UCB is listed on Euronext Brussels (symbol: UCB).
Upcoming eventsAll events
2211 '21Event by: VIB
2309 '21Event by: VIB
0712 '20Event by: Eurasanté